Bioconjugated Nanoparticles Drug Delivery

We have collected information about Bioconjugated Nanoparticles Drug Delivery for you. Follow the links to find out details on Bioconjugated Nanoparticles Drug Delivery.


(PDF) Nanotechnology in cancer therapeutics: Bioconjugated ...

    https://www.researchgate.net/publication/6859123_Nanotechnology_in_cancer_therapeutics_Bioconjugated_nanoparticles_for_drug_delivery
    Nanotechnology in cancer therapeutics: Bioconjugated nanoparticles for drug delivery ... targeted drug delivery vehicles capable of ferrying large doses of chemotherapeutic agents or therapeutic ...

Nanotechnology in cancer therapeutics: bioconjugated ...

    https://mct.aacrjournals.org/content/5/8/1909
    Aug 01, 2006 · Here, we discuss the mechanism of nanoparticle drug delivery through passive and active pathways and the properties and biological utility of self-assembled nanoparticles in cancer therapeutics and promising directions for cancer research. Physiologic and Biologic Characteristics of NanoparticlesAuthor: Rajni Sinha, Gloria J. Kim, Shuming Nie, Dong M. Shin

Nanotechnology in cancer therapeutics: Bioconjugated ...

    https://www.scholars.northwestern.edu/en/publications/nanotechnology-in-cancer-therapeutics-bioconjugated-nanoparticles
    TY - JOUR. T1 - Nanotechnology in cancer therapeutics. T2 - Bioconjugated nanoparticles for drug delivery. AU - Sinha, Rajni. AU - Kim, Gloria J.Author: Rajni Sinha, Gloria J. Kim, Shuming Nie, Dong M. Shin

Emerging trends in clinical implications of bio-conjugated ...

    https://www.sciencedirect.com/science/article/pii/S2215038220300248
    Emerging trends in clinical implications of bio-conjugated silver nanoparticles in drug delivery. ... The prepared nanoparticles were further bioconjugated with folic acid (FA). Darkfield microscopy and scattering spectra of the particles inside the cells confirmed the targeted uptake of the FA conjugated AgNPs by human ovarian cancer cells.Author: Parteek Prasher, Parteek Prasher, Mousmee Sharma, Harish Mudila, Gaurav Gupta, Abhishek Kumar Sharma...

Development of Multifunctional Nanoparticles for Targeted ...

    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3108242/
    Nanoparticles (NPs) show tremendous promise in noninvasive tumor imaging, early detection, and drug delivery , while exhibiting optical, magnetic and structural properties that are not feasible for single molecules. Because of their vast surface area, diverse surface chemistry, and unique pharmacokinetics, a major advantage of NPs over other ...Author: Hari Krishna Sajja, Michael P. East, Hui Mao, Andrew Y. Wang, Shuming Nie, Lily Yang

A Dual Bioconjugated Virus-Like Nanoparticle as a Drug ...

    https://www.mdpi.com/2079-4991/8/4/236
    The fabrication of these dual bioconjugated nanoparticles is simple, and drugs can be easily conjugated with a high coupling efficacy to the VLNPs without any limitation with respect to the cargo’s size or charge, as compared with the pH-responsive system based on tHBcAg VLNPs. ... A Dual Bioconjugated Virus-Like Nanoparticle as a Drug ...Author: Roya Biabanikhankahdani, Kok Lian Ho, Noorjahan Banu Alitheen, Wen Siang Tan

The Chemistry of Bioconjugation in Nanoparticles-Based ...

    https://www.hindawi.com/journals/acmp/2015/198175/
    Nanomedicine is, generally, the application of nanotechnology to medicine. The term nanomedicine includes monitoring, construction of novel drug delivery systems, and any possible future applications of nanotechnology and nanovaccinology. In this review, the most important ligand-nanocarrier and drug-nanocarrier bioconjugations are described.Author: Karolina Werengowska-Ciećwierz, Marek Wiśniewski, Artur P. Terzyk, Sylwester Furmaniak

A Dual Bioconjugated Virus-Like Nanoparticle as a Drug ...

    https://www.mdpi.com/2079-4991/8/4/236/htm
    As an alternative, virus-like nanoparticles (VLNPs) provide an ideal basis for developing specific drug delivery systems for cancer treatments, owing to their biocompatible and biodegradable properties, monodispersity, and symmetrical structures [21,23].One of the intensively characterised VLNPs is the hepatitis B VLNP.Author: Roya Biabanikhankahdani, Kok Lian Ho, Noorjahan Banu Alitheen, Wen Siang Tan

Preparation of Quantum Dot/Drug Nanoparticle Formulations ...

    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3418929/
    However, their rigid matrix does not generally allow for encapsulation and subsequent release of active molecules for conventional drug delivery purposes. Instead, drug molecules can be linked to, or combined with, the nanoparticles for targeted delivery purposes. Bioconjugated quantum dots (QDs) show promise in applications spanning both ...Author: Ken-Tye Yong, Yucheng Wang, Indrajit Roy, Hu Rui, Mark T. Swihart, Wing-Cheung Law, Sang Kyu Kwak, L...

Bovine Serum Albumin Bioconjugated Gold Nanoparticles ...

    https://pubs.acs.org/doi/full/10.1021/jp300585d
    Bovine serum albumin (BSA) conjugated gold (Au) nanoparticles (NPs) were synthesized to explore their applications as drug delivery vehicles in systemic circulation. They showed little hemolysis and cytotoxic responses essentially required for such applications. This study shows some of the important physiochemical aspects needed for an appropriate synthesis of BSA-conjugated NPs where ...Author: Poonam Khullar, Vijender Singh, Aabroo Mahal, Pragnesh N. Dave, Sourbh Thakur, Gurinder Kaur, Jatind...

Searching for Bioconjugated Nanoparticles Drug Delivery?

You can just click the links above. The data is collected for you.

Related Delivery Info